Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 4,335,942 shares, a decrease of 36.3% from the November 30th total of 6,810,216 shares. Based on an average daily trading volume, of 1,818 shares, the short-interest ratio is currently 2,385.0 days. Based on an average daily trading volume, of 1,818 shares, the short-interest ratio is currently 2,385.0 days.

Genomma Lab Internacional Price Performance

Shares of GNMLF opened at $1.06 on Friday. The firm has a 50 day moving average of $0.98 and a 200 day moving average of $1.08. Genomma Lab Internacional has a twelve month low of $0.93 and a twelve month high of $1.43.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct?to?consumer promotions.